Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].
YANG H, FU JH, LIU MZ, FANG WT, WANG JM, CHEN YP, CHEN ZJ, XIANG JQ, YANG HJ, MAO WM, ZHENG X, ZHU CC, KONG M, HAN YT, LI T. YANG H, et al. Among authors: han yt. Zhonghua Yi Xue Za Zhi. 2012 Apr 17;92(15):1028-32. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22781642 Clinical Trial. Chinese.
Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China.
Yang Y, Tan L, Hu J, Li Y, Mao Y, Tian Z, Zhang B, Ma J, Li H, Chen C, Chen K, Han Y, Chen L, Liu J, Yu B, Yu Z, Li Z; Esophageal Cancer Committee of Chinese Anti-Cancer Association. Yang Y, et al. Dis Esophagus. 2022 Nov 15;35(11):doac031. doi: 10.1093/dote/doac031. Dis Esophagus. 2022. PMID: 35649396
Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial).
Yin J, Lin S, Fang Y, Jiao H, Chen Z, Tang H, Gu J, Zhang S, Sun L, Li Y, Han Y, Chen Q, Chen H, Li Z, Tan L. Yin J, et al. J Thorac Dis. 2023 Feb 28;15(2):718-730. doi: 10.21037/jtd-22-1789. Epub 2023 Feb 8. J Thorac Dis. 2023. PMID: 36910109 Free PMC article.
194 results